Full Text
PSY62 PERCEIVED BENEFITS AND DISADVANTAGES OF INTRAVENOUS (IV) BIOLOGIC THERAPY AMONG PATIENTS WITH IMMUNOLOGY CONDITIONS

Abstract

Authors

S. Bolge J. Vanderpoel H. Eldridge S. Mody J. Lofland M. Ingham

Back to Volume 14, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×